Xcorporeal(OTC) XCRP

Xcorporeal, Inc. is a medical device company that previously focused on developing extra-corporeal platform technology for organ replacement devices. Founded in 2001 and headquartered in Lake Forest, California, the company is currently in the process of winding down operations.

Products and Services

• Previously developed devices aimed at replacing human organ functions
• Focused on innovative medical technology solutions
• Engaged in the management of corporate assets through a liquidating trust

Growth Outlook

• Transitioning to a liquidating trust to manage remaining assets
• Historical focus on organ replacement technology indicates potential market interest
• Company's legacy may attract future investment opportunities

Financial Highlights

• Market capitalization stands at $1,515, indicating a niche presence
• Recent trading volume averaged 121,080 shares, reflecting investor interest
• Current ratio of 0.83 suggests liquidity challenges in operations

Xcorporeal, Inc. has shifted its focus from active medical device development to managing its liquidation process. The company's historical expertise in organ replacement technology may still hold relevance in the healthcare sector, potentially attracting interest from investors looking for unique opportunities. The current market capitalization and trading volume indicate a niche presence, while the liquidity challenges highlighted by the current ratio suggest careful management of remaining assets. As the company navigates its winding down phase, the legacy of its innovative technology may continue to resonate within the industry.